Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

Orr, N; Dudbridge, F; Dryden, N; Maguire, S; Novo, D; Perrakis, E; Johnson, N; Ghoussaini, M; Hopper, JL; Southey, MC; Apicella, C; Stone, J; Schmidt, MK; Broeks, A; Van't Veer, LJ; Hogervorst, FB; Fasching, PA; Haeberle, L; Ekici, AB; Beckmann, MW; Gibson, L; Aitken, Z; Warren, H; Sawyer, E; Tomlinson, I; Kerin, MJ; Miller, N; Burwinkel, B; Marme, F; Schneeweiss, A; Sohn, C; Guénel, P; Truong, T; Cordina-Duverger, E; Sanchez, M; Bojesen, SE; Nordestgaard, BG; Nielsen, SF; Flyger, H; Benitez, J; Zamora, MP; Arias Perez, JI; Menéndez, P; Anton-Culver, H; Neuhausen, SL; Brenner, H; Dieffenbach, AK; Arndt, V; Stegmaier, C; Hamann, U; Brauch, H; Justenhoven, C; Brüning, T; Ko, YD; Nevanlinna, H; Aittomäki, K; Blomqvist, C; Khan, S; Bogdanova, N; Dörk, T; Lindblom, A; Margolin, S; Mannermaa, A; Kataja, V; Kosma, VM; Hartikainen, JM; Chenevix-Trench, G; Beesley, J; Lambrechts, D; Moisse, M; Floris, G; Beuselinck, B; Chang-Claude, J; Rudolph, A; Seibold, P; Flesch-Janys, D; Radice, P; Peterlongo, P; Peissel, B; Pensotti, V; Couch, FJ; Olson, JE; Slettedahl, S; Vachon, C; Giles, GG; Milne, RL; McLean, C; Haiman, CA; Henderson, BE; Schumacher, F; Le Marchand, L; Simard, J; Goldberg, MS; Labrèche, F; Dumont, M; Kristensen, V; Alnæs, GG; Nord, S; Borresen-Dale, AL; Zheng, W; Deming-Halverson, S; Shrubsole, M; Long, J; Winqvist, R; Pylkäs, K; Jukkola-Vuorinen, A; Grip, M; Andrulis, IL; Knight, JA; Glendon, G; Tchatchou, S; Devilee, P; Tollenaar, RA; Seynaeve, CM; Van Asperen, CJ; Garcia-Closas, M; Figueroa, J; Chanock, SJ; Lissowska, J; Czene, K; Darabi, H; Eriksson, M; Klevebring, D; Hooning, MJ; Hollestelle, A; van Deurzen, CH; Kriege, M; Hall, P; Li, J; Liu, J; Humphreys, K; Cox, A; Cross, SS; Reed, MW; Pharoah, PD; Dunning, AM; Shah, M; Perkins, BJ; Jakubowska, A; Lubinski, J; Jaworska-Bieniek, K; Durda, K; Ashworth, A; Swerdlow, A; Jones, M; Schoemaker, MJ; Meindl, A; Schmutzler, RK; Olswold, C; Slager, S; Toland, AE; Yannoukakos, D; Muir, K; Lophatananon, A; Stewart-Brown, S; Siriwanarangsan, P; Matsuo, K; Ito, H; Iwata, H; Ishiguro, J; Wu, AH; Tseng, CC; Van Den Berg, D; Stram, DO; Teo, SH; Yip, CH; Kang, P; Ikram, MK; Shu, XO; Lu, W; Gao, YT; Cai, H; Kang, D; Choi, JY; Park, SK; Noh, DY; Hartman, M; Miao, H; Lim, WY; Lee, SC; Sangrajrang, S; Gaborieau, V; Brennan, P; Mckay, J; Wu, PE; Hou, MF; Yu, JC; Shen, CY; Blot, W; Cai, Q; Signorello, LB; Luccarini, C; Bayes, C; Ahmed, S; Maranian, M; Healey, CS; González-Neira, A; Pita, G; Alonso, MR; Álvarez, N; Herrero, D; Tessier, DC; Vincent, D; Bacot, F; Hunter, DJ; Lindstrom, S; Dennis, J; Michailidou, K; Bolla, MK; Easton, DF; dos Santos Silva, I; Fletcher, O; Peto, J; GENICA Network, ; kConFab Investigators, ; Australian Ovarian Cancer Study Group, ; (2015) Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. Human molecular genetics, 24 (10). pp. 2966-84. ISSN 0964-6906 DOI:

Text - Published Version

Download (680kB) | Preview


: We recently identified a novel susceptibility variant, rs865686, for estrogen-receptor positive breast cancer at 9q31.2. Here, we report a fine-mapping analysis of the 9q31.2 susceptibility locus using 43 160 cases and 42 600 controls of European ancestry ascertained from 52 studies and a further 5795 cases and 6624 controls of Asian ancestry from nine studies. Single nucleotide polymorphism (SNP) rs676256 was most strongly associated with risk in Europeans (odds ratios [OR] = 0.90 [0.88-0.92]; P-value = 1.58 × 10(-25)). This SNP is one of a cluster of highly correlated variants, including rs865686, that spans ∼14.5 kb. We identified two additional independent association signals demarcated by SNPs rs10816625 (OR = 1.12 [1.08-1.17]; P-value = 7.89 × 10(-09)) and rs13294895 (OR = 1.09 [1.06-1.12]; P-value = 2.97 × 10(-11)). SNP rs10816625, but not rs13294895, was also associated with risk of breast cancer in Asian individuals (OR = 1.12 [1.06-1.18]; P-value = 2.77 × 10(-05)). Functional genomic annotation using data derived from breast cancer cell-line models indicates that these SNPs localise to putative enhancer elements that bind known drivers of hormone-dependent breast cancer, including ER-α, FOXA1 and GATA-3. In vitro analyses indicate that rs10816625 and rs13294895 have allele-specific effects on enhancer activity and suggest chromatin interactions with the KLF4 gene locus. These results demonstrate the power of dense genotyping in large studies to identify independent susceptibility variants. Analysis of associations using subjects with different ancestry, combined with bioinformatic and genomic characterisation, can provide strong evidence for the likely causative alleles and their functional basis.<br/>

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Related URLs:
PubMed ID: 25652398
Web of Science ID: 355326800022


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item